“The supplier of Estradiol TDP Mylan has assured Pharmac that it can produce enough patches to meet the demand in New Zealand. This is why our proposal is to have two brands funded. Pharmac also funds ...
Shares in Adamis Pharmaceuticals have been poleaxed by ... because of manufacturing issues. Adamis’ stock fell more than 50% into penny share territory after it received the complete response ...
Rural Women New Zealand (RWNZ) says it welcomes recently announced consultation on Pharmac’s funding of ostradiol patches ...
5hon MSN
The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...
Mylan has been in the news for hiking prices on its EpiPen. The stock is flat since we recommended it in March, but we now ...
Explore Phathom Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PHAT. Walmart Posts Upbeat Earnings, Joins Armstrong World Industries ...
Explore Syros Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRS. US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff ...
Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...
Investing.com – Israel stocks were higher after the close on Monday, as gains in the Insurance, Real Estate and Banking sectors ...
The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) stock has hit a distressing milestone, tumbling to a 52-week low of $0.5, with a... Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) stock has tumbled to a 52 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback